Troubleshooting in platelet storage temperature and new perspectives through proteomics

Blood Transfusion

Volumn 8, Issue SUPPL. 3, 2010, Pages

  Giulia Egidi, Maria ^a   D'Alessandro, Angelo ^a   Mandarello, Gabriele ^b   Zolla, Lello ^a  

^a UNIVERSITY OF TUSCIA   (Italy)

^b ASL Viterbo   (Italy)

Author keywords

Cold activation; Platelet concentrates; Platelets; Storage

Indexed keywords

THROMBOCYTE CONCENTRATE;

CRYOPRESERVATION; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRACTICE GUIDELINE; PROTEOMICS; REVIEW; STORAGE TEMPERATURE; THROMBOCYTE ACTIVATION; THROMBOCYTE PRESERVATION; TWO DIMENSIONAL ELECTROPHORESIS;

BLOOD PLATELETS; BLOOD PRESERVATION; HUMANS; PLATELET TRANSFUSION; PROTEOMICS; TEMPERATURE;

EID: 78049393635     PISSN: 17232007     EISSN: None     Source Type: Journal    
DOI: 10.2450/2010.012S     Document Type: Review

References (61)

1. Josefsson EC, Hartwig JH, Hoffmeister KM. Platelet Storage Temperature - How Low Can We Go? Transfus Med Hemother 2007; 34: 253-261.
2. von Ruecker A, Hufnagel P, Dickerhoff R, et al. Qualitative and quantitative changes in platelets after coronary-artery bypass surgery may help identify thrombotic complications and infections. Klin Wochenschr 1989; 67: 1042-1047. (Pubitemid 19252482)
3. Sullivan MT, Wallace EL. Blood collection and transfusion in the United States in 1999. Transfusion 2005; 45: 141-8.
4. Bethesda MD. American Association of Blood Banks (AABB). Standards for blood banks and transfusion services. AABB, 2004.
5. Thon JN, Schubert P, Devine DV. Platelet Storage Lesion: A New Understanding From a Proteomic Perspective. Transfusion Medicine Reviews 2008; 22(4): 268-279.
6. Hoffmeister KM, Felbinger TW, Falet H, et al. The clearance mechanism of chilled blood platelets. Cell 2003; 112: 87-97.
7. Hoffmeister KM, Josefsson EC, Isaac NA, et al. Glycosylation restores survival of chilled blood platelets. Science 2003; 301: 1531-4.
8. Wandall HH, Hoffmeister KM, Sorensen AL, et al. Galactosylation does not prevent the rapid clearance of long-term, 4 degrees C-stored platelets. Blood 2008; 111: 3249-56.
9. Hornsey VS, Drummond O, McMillan L, et al. Cold storage of pooled buffy-coat-derived, leucoreduced platelets in plasma. Vox Sang 2008; 95(1): 26-32.
10. Sørensen AL, Hoffmeister KM, Wandall HH. Glycans and glycosylation of platelets: current concepts and implications for transfusion. Curr Opin Hematol 2008; 15: 606-611.
11. Ferrer F, Rivera J, Lozano ML, et al. Effect of cold-storage on the accumulation of bioreactive substances in platelet concentrates treated with second messenger effectors. Haematologica 2001; 86: 530-536.
12. Shrivastava M. The platelet storage lesion. Transfus Apher Sci 2009; 41: 105-113.
13. White JG, Krivit W. An ultra-structural basis for the shape changes induced in platelets by chilling. Blood 1967; 30: 625-635.
14. Oliver AE, Tablin F, Walker NJ, Crowe JH. The internal calcium concentration of human platelets increases during chilling. Biochim Biophys Acta 1999; 1416: 349-60. (Pubitemid 29065450)
15. Pribluda V, Rotman A. Dynamics of membrane-cytoskeleton interactions in activated blood platelets. Biochemistry 1982; 21: 2825-32.
16. Connor J, Currie LM, Allan H, Livesey SA. Recovery of in vitro functional activity of platelets stored at 48°C and treated with second messenger effectors. Transfusion 1996; 36: 691-698.
17. Vadhan-Raj S, Currie LM, Bueso-Ramos C, et al. Enhanced retention of in vitro functional activity of rhTPO-induced platelets following cryopreservation with Thrombosol and 2% DMSO. British Journal of Haematology 1999; 104: 403-411.
18. Currie LM, Lichtiger B, Livesey SA, et al. Enhanced circulatory parameters of human platelets cryopreserved with second messenger effectors: an in vivo study of 16 volunteer platelet donors. British Journal of Haematology 1999; 105: 826-831. (Pubitemid 29277048)
19. Currie LM, Harper JR, Allan H, Connor J. Inhibition of cytokine accumulation and bacterial growth during storage of platelet concentrates at 4°C with retention of in vitro functional activity. Transfusion 1997; 37: 18-24.
20. Ayukawa O, Nakamura K, Kariyazono H, et al. Enhanced platelet responsiveness due to chilling and its relation to CD40 ligand level and platelet-leukocyte aggregate formation. Blood Coagul Fibrinolysis 2009; 20(3): 176-84.
21. Sandgren P, Hansson M, Gulliksson H, Shanwell A. Storage of buffy-coat-derived platelets in additive solutions at 4 degrees C and 22 degrees C: flow cytometry analysis of platelet glycoprotein expression. Vox Sang. 2007; 93(1): 27-36.
22. Mondoro TH, Vostal JG. Cold temperatures reduce the sensitivity of stored platelets to disaggregating agents. Platelets 2002; 13(1): 11-20.
23. Klinger MHF, Mendoza AS, Kluter H, et al. Storage lesion of human platelets as revealed by ultrathin sections and freeze-fracture replicas. Cell Tissue Res 1994; 276: 417-483.
24. Snyder EL, Rinder HM. Platelet storage-time to come in from the cold? N Engl J Med 2003; 348: 2032-2033.
25. Xavier RG, White AE, Fox SC, et al. Enhanced platelet aggregation and activation under conditions of hypothermia. Thromb Haemost 2007; 98(6): 1266-75.
26. Badlou BA, Ijseldijk MJW, Smid WM, Akkerman JWN. Prolonged platelet preservation by transient metabolic suppression. Transfusion 2005; 45(2): 214-222.
27. Akkerman JWN, Gorter G, Schrama L, Holmsen H. A novel technique for rapid determination of energy consumption in platelets- Demonstration of different energy consumption associated with three secretory responses. Biochem J 1983; 210: 145-155. (Pubitemid 13141431)
28. Akkerman JW, Gorter G. Relation between energy production and adenine nucleotide metabolism in human blood platelets. Biochim Biophys Acta 1980; 590: 107-16.
29. Verhoeven AJ, Mommersteeg ME, Akkerman JW. Comparative studies on the energetics of platelet responses induced by different agonists. Biochem J 1986; 236: 879-87.
30. Verhoeven AJ, Mommersteeg ME, Akkerman JW. Kinetics of energy consumption in human platelets with blocked ATP regeneration. Int J Biochem 1986; 18: 985-90.
31. Badlou BA, Wu YP, Smid WM, Akkerman JWN. Platelet binding and phagocytosis by macrophages. Transfusion 2006; 46(8): 1432-1443.
32. Poole AW, Watson SP. Regulation of cytosolic calcium by collagen in single human platelets. Brit J Pharmacol 1995; 115: 101-106.
33. Roberts DE, McNicol A, Bose R. Mechanism of Collagen Activation in Human Platelets J Biol Chem 2004; 279(7): 19421-19430.
34. Watson SP, Reep B, McConnell RT, Lapetina EG. Collagen stimulates [3H]inositol trisphosphate formation in indomethacin-treated human platelets. Biochem J 1985; 226(3): 831-837.
35. Roberts DE, Bose R. Reverse mode Na+/Ca2+ exchange in the collagen activation of human platelets. Ann N Y Acad Sci 2002; 976: 345-349.
36. Authi KS, Crawford N. Inositol 1,4,5-trisphosphate-induced release of sequestered Ca2+ from highly purified human platelet intracellular membranes. Biochem J 1985; 230: 247-253.
37. Gross B, Wilde J, Quek L, et al. Regulation and Function of WASp in Platelets by the Collagen Receptor, Glycoprotein VI. Blood 2000; 94: 4166-4176.
38. White JG. Effects of colchicine and Vinca alkaloids on human platelets. I. Influence on platelet microtubules and contractile function. Am J Pathol 1968; 53: 281-291.
39. Hoffmeister KM, Falet H, Toker A, et al. Mechanisms of Cold-induced Platelet Actin Assembly. The Journal Of Biological Chemistry 2001; 276(27): 24751-24759. (Pubitemid 33659073)
40. White JG, Rao GH. Microtubule coils versus the surface membrane cytoskeleton in maintenance and restoration of platelet discoid shape. The American journal of pathology 1998; 152(2): 597-609.
41. Winokur R, Hartwig JH. Mechanism of shape change in chilled human platelets. Blood 1995; 85(7): 1796-804.
42. Oliver JA, Monroe DM, Roberts HR, Hoffman M. Thrombin activates factor XI on activated platelets in the absence of factor XII. Arterioscler Thromb Vasc Biol 1999; 19(1): 170-7.
43. Marcus K, Immler D, Sternberger J, Meyer HE. Identification of platelet proteins separated by two-dimensional gel electrophoresis and analyzed by matrix assisted laser desorption/ionization-time of flight-mass spectrometry and detection of tyrosine-phosphorylated proteins. Electrophoresis 2000; 21(13): 2622-36.
44. Martens L, Van DP, Van DJ, et al. The human platelet proteome mapped by peptide-centric proteomics: a functional protein profile. Proteomics 2005; 5: 3193-3204. (Pubitemid 41176487)
45. Moebius J, Zahedi RP, Lewandrowski U, et al. The human platelet membrane proteome reveals several new potential membrane proteins. Mol Cell Proteomics 2005; 4: 1754-1761.
46. O'Neill EE, Brock CJ, von Kriegsheim AF, et al. Towards complete analysis of the platelet proteome. Proteomics 2002; 2: 288-305.
47. Garcia A, Prabhakar S, Brock CJ, et al. Extensive analysis of the human platelet proteome by two-dimensional gel electrophoresis and mass spectrometry. Proteomics 2004; 4: 656-668.
48. Fuste B, Diaz-Ricart M, Jensen MK, et al. TRAP Induces More Intense Tyrosine Phosphorylation than Thrombin with Differential Ultrastructural Features. Am J Pathol 2002; 160: 2245-2252. (Pubitemid 34663414)
49. Garcia A, Prabhakar S, Hughan S, et al. Differential proteome analysis of TRAP-activated platelets: involvement of DOK-2 and phosphorylation of RGS proteins. Blood 2004; 103: 2088-2095.
50. Maguire PB, Fitzgerald DJ. Platelet proteomics. J Thromb Haemost 2003; 1: 1593-601.
51. Coppinger JA, Cagney G, Toomey S, et al. Characterization of the proteins released from activated platelets leads to localization of novel platelet proteins in human atherosclerotic lesions. Blood 2004; 103(6): 2096-2104.
52. Schägger H, von Jagow G. Blue native electrophoresis for isolation of membrane protein complexes in enzymatically active form. Anal Biochem 1991; 199: 223-231.
53. Bentlage H, Coo RD, Laak HT, et al. Human diseases with defects in oxidative phosphorylation. Decreased amounts of assembled oxidative phosphorylation complexes in mitochondrial encephalomyopathies. Eur J Biochem 1995; 227: 909-915.
54. Schägger H. Quantification of oxidative phosphorylation enzymes after blue native electrophoresis and two-dimensional resolution: normal complex I protein amounts in Parkinson's disease conflict with reduced catalytic activities. Electrophoresis 1995; 16: 763-770.
55. Schägger H, Ohm T. Human diseases with defects in oxidative phosphorylation. 2. F1F0 ATP-synthase defects in Alzheimer disease revealed by blue native polyacrylamide gel electrophoresis. Eur J Biochem 1995; 227: 916-921.
56. Yoshinaka K, Kumanogoh H, Nakamura S, Maekawa S. Identification of V-ATPase as a major component in the raft fraction prepared from the synaptic plasma membrane and the synaptic vesicle of rat brain. Neurosci Lett 2004; 363: 168-172. (Pubitemid 38692612)
57. Wang L, Dobberstein B. Oligomeric complexes involved in translocation of proteins across the membrane of the endoplasmic reticulum. FEBS Lett 1999; 457: 316-322.
58. Claeys D, Geering K, Meyer B. Two-dimensional blue native/sodium dodecyl sulfate gel electrophoresis for analysis of multimeric proteins in platelets. Electrophoresis 2005; 26: 1189-1199.
59. Watson SP, Bahou WF, Fitzgerald D, et al. Mapping the platelet proteome: a report of the ISTH Platelet Physiology Subcommittee. J Thromb Haemost 2005; 3: 2098-2101. (Pubitemid 43086070)
60. Dittrich M, Birschmann I, Mietner S, et al. Platelet Protein Interactions: Map, Signaling Components, and Phosphorylation Groundstate. Arterioscler Thromb Vasc Biol 2008; 28: 1326-1331.
61. D'Alessandro A, Righetti PG, Zolla L. The red blood cell proteome and interactome: an update. J Proteome Res 2010; 9: 144-163.